Targeting FDA user fees would leave agency gutted, experts say
Critics worry that the user fee program creates a conflict of interest between the FDA and pharmaceutical companies.
News Medical6d
Healthcare groups urge FDA to act on compounding regulations after GLP-1 medicine shortages
Today, the Obesity Action Coalition (OAC) and The Obesity Society (TOS) sent a letter to the U.S. Food & Drug Administration (FDA), along with more than 20 leading organizations and providers ...
Business Insider6d
Novo Nordisk’s etavopivat granted FDA orphan designation in thalassemia
Novo Nordisk’s (NVO) etavopivat was granted FDA orphan designation for treatment of thalassemias, according to a post on the agency’s website. Published first on TheFly – the ultimate source ...
Benzinga.com1d
FDA Calendar
Exelixis, Inc announced that the U.S. Food and Drug Administration (FDA) has approved CABOMETYX® (cabozantinib) for the treatment of 1) adult and pediatric patients 12 years of age and older with ...
pharmaphorum4d
Sanofi claims FDA okay for drug to treat rare blood disorder CAD
Sanofi has won FDA approval for its sutimlimab for cold agglutinin disease (CAD) at the second time of asking, becoming the first approved therapy for the rare blood disorder in the US.
globo6d
Jornal da EPTV 1ª Edição - Sul de Minas. Placa reconhece curva parecida com o "S" do Senna em Baependi
Jornal da EPTV 1ª Edição - Sul de Minas. Placa reconhece curva parecida com o "S" do Senna em Baependi ...